TAP-GRIN: Interventional Study on Patients With GRIN-related Neurodevelopmental Disorders

计划入组 40 人 · 首次发布于 2026 年 1 月 29 日

Neurodegenerative Diseases Progression Markers (MARKERS-NDD)

计划入组 600 人 · 首次发布于 2024 年 9 月 19 日

Honeycomb: Evaluation of Radiprodil in Children with GRIN-related Disorder

计划入组 24 人 · 首次发布于 2023 年 4 月 19 日

NDD-094

Ad35-GRIN

Ad35-GRIN/ENV

GRIN THERAPEUTICS, INC.

United States

Gain Therapeutics

United States

Trin Therapeutics GmbH

Germany

GRIN Therapeutics Secures $140M Series D and Global Partnership with Angelini Pharma for Radiprodil Development

GRIN Therapeutics Expands Phase 3 Beeline Trial to Europe for Rare Neurodevelopmental Disorder Treatment

FDA Grants Breakthrough Therapy Status to Radiprodil for GRIN-Related Seizure Treatment